Matches in SemOpenAlex for { <https://semopenalex.org/work/W3200520565> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3200520565 endingPage "370" @default.
- W3200520565 startingPage "366" @default.
- W3200520565 abstract "Vitiligo is an acquired depigmenting disorder characterized by the loss of functional melanocytes from the epidermis. Although the etiology of vitiligo is unknown, over the last few years, substantial data from clinical research have greatly supported the Autoimmune theory. Vitiligo has two major forms: progressive and stable. As cytokines are important mediators of immunity, the most important of them are IL-2, IL-6, and tumor necrosis factor-α (TNF-α).We aimed to study the serum level of IL-2, IL-6, and TNF-α in stable and progressive vitiligo and compared them to find a useful lab test to determine the form of vitiligo for diagnose and treatment.Serum IL-2, IL-6, and TNF-α were done by the indirect enzyme-linked immunosorbent assay (ELISA) in 40 cases of stable and progressive vitiligo.Twenty patients had progressive vitiligo and 20 patients were stable vitiligo. In every group, there were seven male patients. Twenty-one patients had a positive family history of vitiligo and four patients had other autoimmune diseases. The average age and familial history between two groups and two genders were not meaningful. The mean serum TNF-α level was significantly higher in progressive than stable vitiligo. No significant difference was observed in the serum levels of IL-2, IL-6 between stable and progressive vitiligo. The mean serum IL-6 and TNF-α had higher levels in male patients.Analysis of TNF-α levels in every age or gender can show us the type of vitiligo, stable or progressive and we can choose the best form of treatment for patients." @default.
- W3200520565 created "2021-09-27" @default.
- W3200520565 creator A5041424902 @default.
- W3200520565 creator A5041556607 @default.
- W3200520565 creator A5043306365 @default.
- W3200520565 date "2021-11-12" @default.
- W3200520565 modified "2023-09-23" @default.
- W3200520565 title "The Study of Serum Level of Interleukin-2, Interleukin-6, and Tumor Necrosis Factor-alpha in Stable and Progressive Vitiligo Patients from Sina Hospital in Tabriz, Iran." @default.
- W3200520565 cites W143063789 @default.
- W3200520565 cites W1485591185 @default.
- W3200520565 cites W1498233245 @default.
- W3200520565 cites W1891817291 @default.
- W3200520565 cites W1982287889 @default.
- W3200520565 cites W2005816495 @default.
- W3200520565 cites W2007438279 @default.
- W3200520565 cites W2012467309 @default.
- W3200520565 cites W2022546685 @default.
- W3200520565 cites W2024754739 @default.
- W3200520565 cites W2035102795 @default.
- W3200520565 cites W2038912264 @default.
- W3200520565 cites W2058630030 @default.
- W3200520565 cites W2068191114 @default.
- W3200520565 cites W2070567299 @default.
- W3200520565 cites W2094128254 @default.
- W3200520565 cites W2098000996 @default.
- W3200520565 cites W2105533289 @default.
- W3200520565 cites W2119662171 @default.
- W3200520565 cites W2158863945 @default.
- W3200520565 cites W2304888905 @default.
- W3200520565 doi "https://doi.org/10.4103/ijd.ijd_300_20" @default.
- W3200520565 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8530078" @default.
- W3200520565 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34759394" @default.
- W3200520565 hasPublicationYear "2021" @default.
- W3200520565 type Work @default.
- W3200520565 sameAs 3200520565 @default.
- W3200520565 citedByCount "1" @default.
- W3200520565 countsByYear W32005205652022 @default.
- W3200520565 crossrefType "journal-article" @default.
- W3200520565 hasAuthorship W3200520565A5041424902 @default.
- W3200520565 hasAuthorship W3200520565A5041556607 @default.
- W3200520565 hasAuthorship W3200520565A5043306365 @default.
- W3200520565 hasConcept C126322002 @default.
- W3200520565 hasConcept C137627325 @default.
- W3200520565 hasConcept C16005928 @default.
- W3200520565 hasConcept C17991360 @default.
- W3200520565 hasConcept C203014093 @default.
- W3200520565 hasConcept C2778690821 @default.
- W3200520565 hasConcept C2779980618 @default.
- W3200520565 hasConcept C2781179581 @default.
- W3200520565 hasConcept C3020084786 @default.
- W3200520565 hasConcept C71924100 @default.
- W3200520565 hasConcept C74172505 @default.
- W3200520565 hasConcept C90924648 @default.
- W3200520565 hasConceptScore W3200520565C126322002 @default.
- W3200520565 hasConceptScore W3200520565C137627325 @default.
- W3200520565 hasConceptScore W3200520565C16005928 @default.
- W3200520565 hasConceptScore W3200520565C17991360 @default.
- W3200520565 hasConceptScore W3200520565C203014093 @default.
- W3200520565 hasConceptScore W3200520565C2778690821 @default.
- W3200520565 hasConceptScore W3200520565C2779980618 @default.
- W3200520565 hasConceptScore W3200520565C2781179581 @default.
- W3200520565 hasConceptScore W3200520565C3020084786 @default.
- W3200520565 hasConceptScore W3200520565C71924100 @default.
- W3200520565 hasConceptScore W3200520565C74172505 @default.
- W3200520565 hasConceptScore W3200520565C90924648 @default.
- W3200520565 hasIssue "4" @default.
- W3200520565 hasLocation W32005205651 @default.
- W3200520565 hasOpenAccess W3200520565 @default.
- W3200520565 hasPrimaryLocation W32005205651 @default.
- W3200520565 hasRelatedWork W14138170 @default.
- W3200520565 hasRelatedWork W15567525 @default.
- W3200520565 hasRelatedWork W16586706 @default.
- W3200520565 hasRelatedWork W1972546 @default.
- W3200520565 hasRelatedWork W20329228 @default.
- W3200520565 hasRelatedWork W2441151 @default.
- W3200520565 hasRelatedWork W4628262 @default.
- W3200520565 hasRelatedWork W9300656 @default.
- W3200520565 hasRelatedWork W9326168 @default.
- W3200520565 hasRelatedWork W9367037 @default.
- W3200520565 hasVolume "66" @default.
- W3200520565 isParatext "false" @default.
- W3200520565 isRetracted "false" @default.
- W3200520565 magId "3200520565" @default.
- W3200520565 workType "article" @default.